*ST Gaosheng (000971): Real Controller 15% Shares Were Auctioned.

*ST Gaosheng (000971) will usher in a new real controller.

On the evening of May 5th, the *ST announcement showed that the auctions of shares held by Reed, the controlling shareholder of Beijing Yu Chi and Reed Investment Co., Ltd. (hereinafter referred to as "Yu Chi Reed") had been completed. The chairman of Zhang Dai, Pak ROK Medical Biotechnology Co., Ltd., which was controlled by the chairman of the board of directors (hereinafter referred to as "Pak ROK medicine"), took the above share price at a bid price of 393 million yuan.

According to the announcement, the auction is still involved in signing and fulfilling the share transfer agreement, paying the balance of the auction and transferring shares. Following the completion of the above procedures, the controlling shareholder and the actual controller will change.

Wei Zhenyu "curtain call"

The company has previously announced that the company bankruptcy administrator will start auctioning on the Beijing property exchange's auction platform at 10 on April 28th. The largest shareholder, Yu Chi Reed, owns 159 million shares of the company, accounting for 15.02% of the total share capital of the company.

Retrospective announcement, the company's largest shareholder Yu Chi Reed shares auction shares have long been interested.

In July 13, 2019, Yu Chi Reed was unable to repay his debts due to insolvency and filed for bankruptcy with the Fangshan District people's Court of Beijing. The court issued a civil ruling in July 11, 2019, ruling to accept Yu Chi Reed's bankruptcy application.

In April 11th, *ST Gaosheng issued the latest announcement on the bankruptcy of the largest shareholder of the company. The announcement said that since November 11, 2019, the administrator has made three public solicitation intentions for Yu Chi Reed's company stock, and the two time the organization quotes procedures, he still can not select the transferee. The manager will publicly choose the transferee to purchase the above shares on the auction platform of the Beijing property exchange.

It is worth mentioning that the second largest shareholder of the same controlling company, landing industry, also applied for bankruptcy reorganization in Xiantao court last year because it could not repay debts due to insolvency. According to previous announcement, Xiantao court issued the "civil ruling" in July 3, 2019 and decided to accept the application for bankruptcy reorganization of LAN Ding.

*ST Gao Sheng announcement said that as of now, the blue Ting industrial holding company shares of 90 million 180 thousand shares, and Yu Chi Reed by the same actual controller Wei Zhenyu control.

In addition, in July 23, 2019, the information of Ali judicial auction platform showed that Shenzhen Qianhai high search Cci Capital Ltd had won 132 million yuan for the auction of *ST by the Shenzhen intermediate people's court, which accounted for 5.09% of the total share capital, and the average price of the transaction was about 2.38 yuan / share, and the auction price was about 2.47 yuan / share, which was not far from the price of the previous auction. The price of the auction was 55 million 360 thousand yuan.

At the same time, *ST high rise of the real controller change expectations also let the stock prices continue to rise, nearly 5 trading days have recorded 4 daily limit.

Long sought after offer?

What is the background of the medicine? Data from sky eye showed that the registration time of March 1, 2006 was 21 million 135 thousand. The registered address is No. 99 Huan Huan Nan Road, Tianjin free trade pilot area (Airport Economic Zone).

The business scope of parrok medicine is biotechnology development, consultation and transfer; international trade; import and export of goods and technologies; sales of medical devices (in accordance with the license for medical device operation); production of I 6840- in vitro diagnostic reagents and equipment.

The shareholding structure of Bai ROK medicine is simple. Zhang Dai, a natural person, owns 100% of the company's shareholding. Looking at the change of stock ownership information, Zhang Dai can find that in September 17, 2018, he obtained the full stake of 100 grams of medicine from Tianjin Jiacheng Shun long Cci Capital Ltd, Tianjin Di Wang Group Co., Ltd., Jiang Wenzheng and Rong Ping Ping. The 100 gram medicine also becomes the natural person sole proprietorship enterprise from this.

What we need to pay attention to is that Zhang Daizi started to hold the post of *ST senior chairman, director and general manager in January 5th this year. Therefore, the auction of shares of Reed, which is now an important part of the company, should have been planned.

Public information shows that Zhang Dai was born in July 1972, Chinese nationality, senior engineer in communications. In the past five years, it has been a member of China Electric wisdom cloud Holdings Limited (hereinafter referred to as "CLP Zhi Yun"), CEO, chairman and general manager of Guiyang Zhong Dian Hi Tech Data Technology Co., Ltd., chairman of China Cloud times data technology (Beijing) Co., Ltd., Changzhi Zhi Yun Rong and big data Co., Ltd., general manager and general manager, executive director of Shanxi Cloud Data Technology Co., Ltd. Limited company director and general manager, SinoCloud Group Limited executive director and other posts.

Zhang Dai is currently chairman of Cci Capital Ltd (Guiyang) hospital, director of Guizhou Xin Yi Kang health industry Co., Ltd., and executive director and general manager of Tianjin Biotech Pharmaceutical Biotechnology Co., Ltd., Guizhou.

What we need to pay attention to is that Zhang Daiceng, who is in charge of CEO, has relations with *ST.

Announcements show that in October 25, 2018, *ST Gaosheng planned to buy 400 million yuan Zhong Yun cloud data technology (Lianyungang) Limited and Zhong Tong Ke Yun real estate (Lianyungang) Limited. The acquisition attracted the attention of the exchange. At that time, the exchange raised 7 core doubts in the letter of concern. In November 31, 2019, *ST announced the decision to terminate the takeover.